
Discussing the Role of MRD in CLL With Talal Hilal, MD
The HemOnc Pulse
00:00
Introduction
Exploring the evolution and significance of measurable residual disease (MRD) terminology in Chronic Lymphocytic Leukemia, highlighting its detection by advanced methods like flow cytometry and DNA sequencing as a crucial response measure.
Transcript
Play full episode